scispace - formally typeset
Search or ask a question

Showing papers on "Biofilm matrix published in 1993"


Journal ArticleDOI
TL;DR: This paper describes the development of a model utilizing an implant-S.
Abstract: Infections of implanted devices are of increasing frequency and importance, representing a significant limitation of many therapeutic modalities. There are puzzling features of implant-associated infection including the changes in microbial flora, the tendency to chronicity and impaired responses to conservative modes of treatment. The concept of the bacterial biofilm as a shielding mechanism generated by bacteria adherent to artificial surfaces has recently been proposed as an explanation for these features. The biofilm is a term applied to a complex comprising the implant surface, adherent bacteria and a specialized matrix enclosing the bacteria. The matrix of the biofilm is an electrostatically charged glue-like extracellular polymer derived by bacterial enzymes acting on tissue carbohydrates, formed by bacteria when adherent to surfaces. This matrix binds the bacteria to the surface providing a sequestration affording selective protection against harmful elements of the environment, especially mechanisms of host defenses and antimicrobial agents. These biological systems are complex to study because of the dynamic interaction of the microbial variables, host defenses, properties of synthetic materials and the biofilm matrix itself. There is a need for a laboratory model in which the variables can be controlled permitting the researcher to examine the outcomes of modifying one variable at a time in a planned and orderly manner. The practical way to attain this end is the conduct of studies in a stable reproducible animal model of localized biofilm-implant infection. Staphylococcus epidermidis is a representative of the class of microorganisms predominant in implant-associated infection. This paper describes the development of a model utilizing an implant-S. epidermidis-biofilm infection localized to the peritoneal cavity of the mouse. The natural history of the infection has been well documented and is stable in all respects for periods exceeding 3 months. This chronicity is especially advantageous in analyzing the impact of long-term therapeutic modalities and necessary periods of recovery and assessment. A representative example of an experimental use of this model to determine the relative efficacy of antibiotic therapeutic regimes is described, demonstrating its scope and efficacy.

16 citations


Book ChapterDOI
TL;DR: AbstractPart VIII consists of abstracts from the following articles:.
Abstract: s of poster presentations 44 P010 Antifungal agents induces alteration in the matrix composition of candida glabrata biofilms Rodrigues, Celia (Minho University, Departement of Biological Engineering Department, Braga ); Fonseca, Elza (Minho University, Departement of Biological Engineering Department, Braga , AUT); Goncalves, Bruna (Minho University, Departement of Biological Engineering Department, Braga ); Bogas, Diana (Minho University, Departement of Biological Engineering Department, Braga ); Silva, Sonia (Minho University, Departement of Biological Engineering Department, Braga ); Azeredo, Joana (Minho University, Departement of Biological Engineering Department, Braga ); Henriques, Mariana (Minho University, Departement of Biological Engineering Department, Braga ) Candida glabrata has emerged as the second most prevalent pathogen, after Candida albicans, in mucosal and invasive fungal infection. Its ability to form biofilms has been considered one of the most important virulence factors, since they present a high resistance to antifungal agents used in fungal infections treatment. Moreover, there is a lack of information about the physiological response of C. glabrata biofilms to antifungal agents. Thus, the aim of this study was to evaluate the effect of different antifungal agents on C. glabrata biofilm composition and the influence in related resistance genes expression. For that C. glabrata biofilms were formed in the presence of fluconazole (Flu), voriconazole (Vrz) and amphotericin B (AmB). Biofilm matrix composition was evaluated in terms of polysaccharides, proteins and ergosterol and ERG genes expression was also assessed. As expected C. glabrata biofilms are more resistant to Flu, Vrz and AmB than planktonic cells. . Although in a strain dependent manner, polysaccharides were increased in the presence of the antifungals, in opposition to proteins, which decreased in the presence of AmB and Vrz. Due to the interaction of these agents with ergosterol, even in different ways, we evaluated, for the first time, the presence of this compound in the extracelluar matrix. It was noticed that ergosterol was, in fact, present in all the matrices and in general it increased with the presence of the drugs. Therefore, there is an obvious answer of biofilm cells to the stress induced by the different agents, that caused and alteration of matrix composition. In order to determine if the increased concentration of ergosterol in the biofilm matrix was caused by an up-regulation of proteins responsible for ergosterol synthesis, ERG expression was evaluated.. Although ERG gene expression was very strain dependent is was possible to verify that some genes, as ERG11 and ERG6, were upregulated in biofilm cells. Interestingly one strain was unable to express ERG genes when grown in the presence of Vrz. It was then possible to conclude that biofilm cells upon exposure to antifungal agents overexpress ERG genes, which seems to contribute to an increase in ergosterol concentration in the biofilm matrix.

6 citations